Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Institute of Medicinal Molecular Design, Inc.”

17 pharma patents match "Institute of Medicinal Molecular Design, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 17
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 17 pharmaceutical patents matching "Institute of Medicinal Molecular Design, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

17 results for “Institute of Medicinal Molecular Design, Inc.” · 30,257 patents in full index Clear search

  1. US 8263657

    Inhibitors against the production and release of inflammatory cytokines

    Institute of Medicinal Molecular Design, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted

  2. US 8097610

    Derivative having PPAR agonistic activity

    Institute of Medicinal Molecular Design, Inc. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted

  3. US 8097759

    Inflammatory cytokine release inhibitor

    Institute of Medicinal Molecular Design, Inc. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted

  4. US 8044236

    Carboxilic acid derivatives

    Institute of Medicinal Molecular Design, Inc. · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  5. US 7998992

    Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1

    Institute of Medicinal Molecular Design, Inc. · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  6. US 7884234

    N-phenyloxamide derivatives

    Institute of Medicinal Molecular Design, Inc. · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  7. US 7700655

    Antiallergic agents

    Institute of Medicinal Molecular Design, Inc. · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted

  8. US 7671058

    N-(3,4-disubstituted phenyl) salicylamide derivatives

    Institute of Medicinal Molecular Design, Inc. · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted

  9. US 7626042

    O-substituted hydroxyaryl derivatives

    Institute of Medicinal Molecular Design, Inc. · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted

  10. US 7598418

    Amide derivatives

    Institute of Medicinal Molecular Design, Inc. · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted

  11. US 7547716

    Sulfonamide derivatives

    Institute of Medicinal Molecular Design, Inc. · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted

  12. US 7411076

    Coumarin derivative

    Institute of Medicinal Molecular Design, Inc. · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted

  13. US 6869959

    Heterocyclic carboxylic acid derivatives

    Institute of Medicinal Molecular Design, Inc. · Granted Mar 22, 2005 · Expires Mar 17, 2025

    expired

  14. US 6838574

    Dicarba-closo-dodecarborane derivatives

    Institute of Medicinal Molecular Design, Inc. · Granted Jan 4, 2005 · Expires Dec 30, 2024

    expired

  15. US 6476017

    Compounds activating pharmacological effect of retinoids

    Institute of Medicinal Molecular Design, Inc. · Granted Nov 5, 2002 · Expires Oct 31, 2022

    expired

  16. US 6458782

    Remedies for diabetes

    Institute of Medicinal Molecular Design, Inc. · Granted Oct 1, 2002 · Expires Sep 26, 2022

    expired

  17. US 6121256

    Compounds activating pharmacological effect of retinoids

    Institute of Medicinal Molecular Design, Inc. · Granted Sep 19, 2000 · Expires Sep 14, 2020

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.